Security key
528872302
LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)
CUSIP: 528872302
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 171,815,966
- Total 13F value
- $412,351,239
- Share change
- -11,073,000
- Put/Call ratio
- 20%
- SEC-reported price per share
- $2.40
- Number of holders
- 114
- Value change
- -$24,970,122
- Number of buys
- 59
- Number of sells
- 51
- Shares outstanding
- 444,558,533
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
114
Top holders
10
LXRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
LEXICON PHARMACEUTICALS, INC. SEC filings
LEXICON PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 528872302
Recent filing periods:
Ownership snapshot
Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Artal Group S.A.
Disclosed value leader
Artal Group S.A.
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 26%
Showing 1-6 of 15 holder rows.
Quick read
Artal Group S.A. leads the comparable SEC ownership view at 26%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Artal Group S.A.'s linked filing trail.
Comparable ownership
Top 5
Artal Group S.A.
26%
BVF INC/IL
5.5%
BlackRock Finance, Inc.
1.6%
VANGUARD GROUP INC
1.3%
JPMORGAN CHASE & CO
0.68%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Artal Group S.A. |
13F
Company
|
26%
|
$179,857,000
117,553,284 shares
|
— | 31 Dec 2023 |
| BVF INC/IL |
13F
Company
|
5.5%
|
$37,386,517
24,435,632 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
1.6%
|
$10,717,885
7,005,153 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$9,149,968
5,980,371 shares
|
— | 31 Dec 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.68%
|
$4,656,235
3,043,291 shares
|
— | 31 Dec 2023 |
| NEA Management Company, LLC |
13F
Company
|
0.54%
|
$3,644,898
2,382,286 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
171,815,966
Rows available
114
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
114
Q1 2024 holders
114
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend